Dr. Martens plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DRMTY research report →
Price Chart
About the company
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks.
- CEO
- Ije Nwokorie
- IPO
- 2022
- Employees
- 2,377
- HQ
- London, GL, GB
Get TickerSpark's AI analysis on DRMTY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $885.33M
- P/E
- 27.23
- PEG
- 0.06
- P/S
- 0.85
- P/B
- 1.80
- EV/EBITDA
- 5.94
- Div Yield
- 3.76%
- Gross Margin
- 57.17%
- Op Margin
- 10.01%
- Net Margin
- 3.11%
- ROE
- 6.89%
- ROIC
- 7.30%
Latest fiscal year · YoY change
- Revenue
- $764.90M-2.9%
- Gross Profit
- $506.00M-1.1%
- Op Income
- $140.10M
- Net Income
- $23.80M+428.9%
- EPS
- $0.05+394.0%
- OCF Growth
- -35.0%
- FCF Growth
- -33.5%
- 52W High
- $2.57
- 52W Low
- $1.43
- 50D MA
- $2.02
- 200D MA
- $2.00
- Beta
- 0.26
- RSI (14)
- 32
- Avg Volume
- 464
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the DRMTY Q2 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 52.1%
- Shares Outstanding
- 478.56M
- Float Shares
- 249.37M
Our DRMTY coverage
Recent articles, reports, and earnings notes.
No research on DRMTY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DRMTY report →Dr. Martens plc (DRMTY) Q4 2026 Earnings Call Transcript
seekingalpha.com · May 19
Dr Martens profits jump as turnaround gains grip
proactiveinvestors.co.uk · May 19
Dr Martens' turnaround gathers pace as annual profit jumps 61%
reuters.com · May 19
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call Transcript
seekingalpha.com · Jan 27
Dr. Martens Revenue Drops on Europe, Middle East and Africa Weakness
wsj.com · Jan 27
Dr Martens sales growth slows but 'significant' profit increase still expected
proactiveinvestors.co.uk · Jan 27
Dr. Martens plc (DRMTY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Nov 20
Dr Martens drops despite results in line with forecasts
proactiveinvestors.co.uk · Nov 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.